16.40
Enliven Therapeutics Inc 주식(ELVN)의 최신 뉴스
Enliven Therapeutics to Present at Upcoming Investor Conferences - PR Newswire
(ELVN) Proactive Strategies - news.stocktradersdaily.com
Enliven Therapeutics chief scientific officer sells $81,533 in stock - Investing.com Australia
Enliven Therapeutics chief scientific officer sells $81,533 in stock By Investing.com - Investing.com India
Enliven Therapeutics, Inc. (NASDAQ:ELVN) Shares Purchased by Northern Trust Corp - Defense World
HC Wainwright Issues Pessimistic Outlook for ELVN Earnings - Defense World
Jones Trading Has Lowered Expectations for Enliven Therapeutics (NASDAQ:ELVN) Stock Price - Defense World
Q1 Earnings Forecast for ELVN Issued By HC Wainwright - Defense World
HC Wainwright Raises Enliven Therapeutics (NASDAQ:ELVN) Price Target to $40.00 - Defense World
Jones Trading Lowers Price Target for Enliven Therapeutics (ELVN) | ELVN Stock News - GuruFocus
Enliven (ELVN) Stock Target Cut Amid Mixed Market Reaction | ELVN Stock News - GuruFocus
Enliven Therapeutics, Inc. (NASDAQ:ELVN) Holdings Lifted by Price T Rowe Associates Inc. MD - Defense World
Enliven Therapeutics (NASDAQ:ELVN) Stock Price Down 7.6% Following Weak Earnings - Defense World
Enliven Therapeutics Reports Q1 Results and Pipeline Progress - TipRanks
Enliven Therapeutics stock target raised to $40 at H.C. Wainwright By Investing.com - Investing.com South Africa
Enliven Therapeutics: Cash runway can fund ops through late 2027 - BizWest
Enliven Therapeutics (ELVN) Target Price Raised by HC Wainwright & Co. | ELVN Stock News - GuruFocus
Enliven Therapeutics stock target raised to $40 at H.C. Wainwright - Investing.com Australia
H.C. Wainwright Increases Price Target for Enliven (ELVN) Post Q - GuruFocus
H.C. Wainwright Increases Price Target for Enliven (ELVN) Post Q1 Report | ELVN Stock News - GuruFocus
Enliven reports positive Phase 1 trial data for ELVN-001 in CML - Investing.com Nigeria
Tower Research Capital LLC TRC Boosts Stock Holdings in Enliven Therapeutics, Inc. (NASDAQ:ELVN) - Defense World
Enliven Therapeutics Reports First Quarter Financial Results and Provides a Business Update - PR Newswire
Enliven reports positive Phase 1 trial data for ELVN-001 in CML By Investing.com - Investing.com South Africa
Enliven Therapeutics Says ELVN-001 Shows Favorable Safety And Tolerability Profile - marketscreener.com
Enliven Therapeutics Announces Updated Positive Data from Phase 1 Clinical Trial of ELVN-001 in CML and Oral Presentation at the EHA 2025 Congress - The Malaysian Reserve
Enliven (ELVN) Reports Positive Results from ENABLE Trial for Chronic Myeloid Leukemia | ELVN Stock News - GuruFocus
Breakthrough CML Drug ELVN-001 Achieves 44% Response Rate in Heavily Pretreated PatientsKey Data Revealed - Stock Titan
(ELVN) Investment Analysis - news.stocktradersdaily.com
Enliven Therapeutics (ELVN) Expected to Announce Earnings on Tuesday - Defense World
Wells Fargo & Company MN Has $375,000 Stock Holdings in Enliven Therapeutics, Inc. (NASDAQ:ELVN) - Defense World
Invesco Ltd. Buys 508 Shares of Enliven Therapeutics, Inc. (NASDAQ:ELVN) - Defense World
Barclays PLC Has $1.45 Million Holdings in Enliven Therapeutics, Inc. (NASDAQ:ELVN) - Defense World
Enliven Therapeutics (NASDAQ:ELVN) Sets New 52-Week Low on Insider Selling - Defense World
JPMorgan Chase & Co. Trims Stock Position in Enliven Therapeutics, Inc. (NASDAQ:ELVN) - Defense World
Enliven (ELVN) Gains Attention as EHA Data Release Approaches | - GuruFocus
Trading (ELVN) With Integrated Risk Controls - news.stocktradersdaily.com
Enliven Therapeutics, Inc. (NASDAQ:ELVN) Stake Lowered by Legal & General Group Plc - Defense World
Enliven Therapeutics chief scientific officer sells $80,365 in stock By Investing.com - Investing.com India
Enliven Therapeutics chief scientific officer sells $80,365 in stock - Investing.com Australia
Enliven Therapeutics Inc (ELVN) shows promising results - uspostnews.com
Enliven Therapeutics: Awaiting Additional Trial Data (NASDAQ:ELVN) - Seeking Alpha
Geode Capital Management LLC Acquires 12,510 Shares of Enliven Therapeutics, Inc. (NASDAQ:ELVN) - Defense World
Can you now get a good deal on Enliven Therapeutics Inc’s shares? - uspostnews.com
(ELVN) Trading Report - news.stocktradersdaily.com
Vanguard Group Inc. Purchases 55,283 Shares of Enliven Therapeutics, Inc. (NASDAQ:ELVN) - Defense World
Enliven Therapeutics, Inc. (NASDAQ:ELVN) Stake Boosted by Wellington Management Group LLP - Defense World
KLP Kapitalforvaltning AS Makes New $97,000 Investment in Enliven Therapeutics, Inc. (NASDAQ:ELVN) - Defense World
Ratios Revealed: Decoding Enliven Therapeutics Inc (ELVN)’s Financial Health - DWinneX
Corebridge Financial Inc. Trims Holdings in Enliven Therapeutics, Inc. (NASDAQ:ELVN) - Defense World
Enliven Therapeutics COO Anish Patel sells shares worth $120,268 By Investing.com - Investing.com India
Enliven Therapeutics COO Anish Patel sells shares worth $120,268 - Investing.com Australia
자본화:
|
볼륨(24시간):